Trial intelligence / Profile preview

CBD on Sleep Quality Following Late Evening Exercise

NCT07570472Phase 2Recruiting

Sponsor
KU Leuven
Start
Mar 2026
Primary completion
May 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of cannabidiol in sleep disorder, sponsored by KU Leuven. Started Mar 2026; status: recruiting.

02

Drugs

cannabidiol
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT07570472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07570472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call